Wednesday 3 August 2022 11:19 PM America faces shortage of Adderall trends now

View
comments

America is facing a shortage of Adderall as supply chain issues striking the nation's largest manufacturer of the drug combined with record demand have left manufacturers of the popular drug reeling.

Teva Pharmaceuticals, an Israeli company, told Bloomberg that 'supply disruptions' affecting one unnamed manufacturing facility have led to packaging constraints. The shortage will affect branded and generic forms of the drug.

These issues arise as increased scrutiny is placed on the amount of Adderall being distributed in the U.S. Popular online clinics like Cerebral and Done have faced allegations of misusing and over-prescribing the drugs. Data also shows the number of people receiving the drugs in America outweighs the amount who have been diagnosed with ADHD.

Teva accounts for more than a quarter of Adderall market share in the U.S., meaning a shortage in its ranks could lead to some having a hard time finding the drug. The Food and Drug Administration (FDA) does not yet report a shortage of the drug, though, according to Bloomberg.

Teva is America's leading producer of both name brand and generic versions of the drug.